Global IV Flush Syringe Market Size (2024 - 2029)

The IV flush syringe market is experiencing growth driven by increasing awareness of its benefits and the rising prevalence of chronic diseases, which necessitate hospitalizations and the use of these syringes. The market size is influenced by the demand for saline and heparin IV flush syringes, although it faced challenges during the COVID-19 pandemic due to reduced hospital admissions and supply chain disruptions. Despite these challenges, the market is expected to expand as healthcare providers recognize the efficiency and infection risk reduction offered by IV flush syringes. However, factors such as price fluctuations, limited training programs, and competition from other syringe types are constraining the market's growth potential.

Market Size of Global IV Flush Syringe Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
iv flush syringe market size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.00 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration High

Major Players

iv flush syringe market share

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

IV Flush Syringe Market Analysis

The IV flush syringe market is expected to register a CAGR of 6.0% over the forecast period, 2022-2027.

The advent of COVID-19 resulted in burdening of healthcare infrastructure worldwide as most elective healthcare treatments were postponed. Moreover, the demand for these IV flush syringes such as saline IV flush syringes and heparin IV flush syringes witnessed a decline due to a decline in hospital admission of non-covid patients. Also, the number of surgeries has been reduced due to a lack of healthcare professionals, and supply chain & logistic disruption has reduced the demand for the product in the market. Many of the patients suffering from chronic diseases were treated remotely from home to prevent the risk of disease transmission and unburden healthcare facilities. Thus, the market would undergo a negative impact due to a lack of demand for IV flush syringes.

Furthermore, increasing chronic disorders are expected to propel the demand for IV flush syringes. In the year 2020, as per the data provided by the healthcare cost & utilization project, cardiac diseases, arthritis, COPD, and diabetes are factors supporting in-patient hospital stays in the United States. For instance, In 2020, as per the Centers for Disease Control and Prevention estimates suggested a higher diagnosed prevalence of COPD in the United States with 17,455,605 diagnosed cases in 2020, which might increase in 2030, thus the increasing cases of COPD in the respective country would raise the rate of hospitalizations which would generate the need for IV flush syringes in the treatment process. Also, In the year 2019 as per a national health council study, the number is projected to grow to an estimated 157 million, with 81 million having multiple chronic conditions in the United States. Thus, the increasing number of chronic diseases is generating the need for the usage of IV flush syringes market.

Increasing awareness about the benefits of using an IV Flush Syringe also drives the growth of this market. Health care providers use IV flushes to clear out intravenous lines that deliver medicine directly into the veins of a patient. Flushes are administered before and after starting IV medication drips or fluids in patients. This ensures the lines stay clean and prevents blockages. When used correctly, IV flush syringes could make life much easier for health care providers and patients. The devices increase workflow efficiency in care settings and usually decrease the risk of infection. They also decrease the risk of needlestick injuries among health care professionals. For instance, BD PosiFlush SP Pre-Filled Saline Syringe assist in improving clinician efficiency and workflow by eliminating steps and time involved in the manual preparation of saline syringes. Thus, the advantages associated with IV Flush syringes are rising demand for the product which is boosting the market growth.

However, fluctuations in the prices of the final product are quietly hampering the demand of the market. Lack of sufficient knowledge in handling the syringes owing to few training programs is restraining the demand of the market. Replacement of other types of syringes instead of IV flush syringes is restricting the growth of the market.

IV Flush Syringe Industry Segmentation

As per the scope of the report, IV flush syringes are medical devices utilized to clear intravenous lines. When utilized correctly, saline flushes are generally safe and well tolerated by patients, but complications could occur. Although rare, IV flush syringes could introduce air embolisms into a vein, that could lead to heart attacks, strokes, and respiratory failure. Contaminated syringes have been linked to serious bacterial infections in patients. In rare cases, a serious allergic reaction may occur. The IV Flush Syringe market is segmented by Product (Saline IV Flush Syringe and Heparin IV Flush Syringe), End-User (Hospital & Clinics, Ambulatory Surgical centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product
Saline IV Flush Syringe
Heparin IV Flush Syringe
By End-User
Hospital & Clinics
Ambulatory Surgical centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Need A Different Region Or Segment?
Customize Now

Global IV Flush Syringe Market Size Summary

The IV flush syringe market is poised for growth, driven by the increasing prevalence of chronic disorders and the rising number of hospital admissions. The market experienced a temporary setback during the COVID-19 pandemic due to reduced hospital admissions and elective surgeries, which impacted the demand for IV flush syringes. However, as healthcare systems recover and the number of chronic conditions such as COPD, diabetes, and cardiac diseases continues to rise, the demand for these syringes is expected to increase. The awareness of the benefits of IV flush syringes, which enhance workflow efficiency and reduce infection risks, further propels market growth. Despite challenges such as price fluctuations and limited training programs, the market is supported by the significant share held by hospitals and clinics, where the need for IV flush syringes is critical for patient care.

North America holds a substantial share of the IV flush syringe market, with the United States leading due to its advanced healthcare infrastructure and high incidence of chronic disorders. The region's acceptance of novel technologies and ongoing research and development activities contribute to market expansion. Key players in the market, including BD, B. Braun Melsungen AG, and Cardinal Health, are investing in manufacturing expansions and innovative product developments to strengthen their market positions. These companies are also engaging in strategic partnerships and acquisitions to enhance their product offerings and production capabilities. As the demand for IV flush syringes continues to grow, driven by the increasing number of surgeries and hospitalizations, the market is expected to experience significant growth in the coming years.

Explore More

Global IV Flush Syringe Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rise In Awareness And Favorable Guidelines For Single Use Syringes

      2. 1.2.2 Rising Burden Of Chronic Diseases And Infectious Diseases

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Guidelines coupled with Increasing number of recalls for IV Flush Syringes

      2. 1.3.2 Lack of Sufficient Knowledge in Handling the Syringes due to Less Training Programs

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product

      1. 2.1.1 Saline IV Flush Syringe

      2. 2.1.2 Heparin IV Flush Syringe

    2. 2.2 By End-User

      1. 2.2.1 Hospital & Clinics

      2. 2.2.2 Ambulatory Surgical centers

      3. 2.2.3 Others

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Rest of the World

Global IV Flush Syringe Market Size FAQs

The Global IV Flush Syringe Market is projected to register a CAGR of 6% during the forecast period (2024-2029)

BD (Becton, Dickinson and Company) , B. Braun Melsungen AG , Cardinal Health , Nipro Corporation and Medline Industries, LP are the major companies operating in the Global IV Flush Syringe Market.

IV Flush Syringe Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)